on BASTIDE (EPA:BLC)
Sustained growth for the Bastide Group in the first half of 2025-2026
The Bastide Group, specializing in home healthcare services, posted organic growth of 8.2% in the first half of fiscal year 2025-2026. Revenue reached €260.4 million, despite a price reduction for sleep apnea treatments. Home healthcare services, covering respiratory care, nutrition, infusion therapy, diabetes, and ostomy care, continued to grow at a solid rate of 7.9%.
The home care segment showed significant growth of 8.4% in the second quarter, driven by strong performance in the institutional sector. This solid expansion allows the Bastide Group to confirm its annual revenue target of €510 million, while maintaining an operating margin of around 9%.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all BASTIDE news